Latest Product Launch News

EBOS Group Limited posted a strong half-year performance with underlying EBITDA up 7.1% to $291 million, driven by growth in healthcare and animal care segments, while maintaining its interim dividend amid the loss of the Chemist Warehouse contract.

HUB24 has delivered a robust half-year performance for 1HFY25, marked by significant revenue growth, record net inflows, and expanding adviser engagement, reinforcing its leadership in Australia’s wealth management technology sector.

Baby Bunting has reported a robust first half for FY25, with net profit after tax rising 37% to $4.8 million and sales edging up 2.4%. The company’s strategic initiatives around margin improvement and store expansion underpin a stable outlook for the full year.

Audinate delivered 1H25 results above guidance despite a transitional year marked by inventory adjustments, with software revenue growth and strategic product launches setting the stage for a return to growth in FY26.

Cochlear Limited posted a 5% increase in sales revenue to $1.17 billion for the half year ended December 2024, driven by strong cochlear and acoustic implant growth despite a decline in Services revenue. The company anticipates FY25 underlying net profit at the lower end of guidance amid increased cloud investments and prepares for new product launches.

Domain Holdings Australia Limited reported a robust 7% revenue increase to $217.2 million in H1 2025, driven by strong adoption of its Marketplace strategy and innovative products like Platinum Edge and Audience Boost. Despite some segment challenges, the company maintains a positive outlook with stable margins and ongoing technology investments.

Amotiv Limited posted a modest 2.3% revenue increase for H1 FY25 despite a 35.8% plunge in net profit after tax, driven by impairments and restructuring. The company signals optimism for FY25 growth, underpinned by new product launches and disciplined cost management.

Breville Group Limited delivered a robust first half for FY25, posting double-digit revenue growth and a significant rise in net profit, underpinned by strong consumer demand and proactive inventory management to counter tariff risks.

Breville Group Limited reported a robust half-year performance with 10.1% revenue growth and a 16.1% rise in net profit, driven by strong coffee category sales and strategic product launches. Despite macroeconomic headwinds and tariff concerns, the company maintains a confident outlook for FY25.

CSL Limited reported a solid half-year performance with 5% revenue growth and a 7% rise in net profit, driven by strong demand in its Behring and Vifor segments despite challenges in Seqirus. The company reaffirmed its full-year NPATA guidance of 10-13%, signaling confidence in its operational momentum.

CSL Limited posted a robust half-year performance with NPATA rising 5% at constant currency, driven by strong growth in CSL Behring and CSL Vifor despite challenges in its influenza vaccine segment. The company reaffirmed its FY25 guidance, anticipating double-digit earnings growth.

CSL Limited reported a solid 5% revenue increase and 6% rise in net profit after tax for the half year ended December 2024, underpinned by robust performance in its plasma therapies business despite headwinds in its influenza vaccine segment.